Saito S, Suzuki K, Yoshimoto K, Kondo Y, et al. Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients. Clin Exp Rheumatol 2022 Dec 15. doi: 10.55563.
PMID: 36533996